ISMP Medication Safety Alert!®

Community/Ambulatory

A valuable resource to reduce medication error risk in outpatient settings

The ISMP Medication Safety Alert!®Community/Ambulatory Care is a digital newsletter, published monthly for healthcare practitioners in ambulatory settings, including community pharmacies, specialty pharmacies, outpatient clinics, physician offices, and state institutions.

Who reads this newsletter?

  • Community/ambulatory/specialty care pharmacists
  • Pharmacy managers and executives
  • Pharmacy technicians and other pharmacy staff
  • Physicians and nurses in ambulatory practice
  • Anyone concerned with medication safety

Subscription Options

Online access to twelve (12) issues per year. You will receive a reminder notice via email to renew your annual subscription before your subscription expires. Your subscription will not automatically renew.
Single issues are available for purchase. 

Academic-based subscription: contact ISMP for pricing

Pharmaceutical Industry (and other healthcare related companies): contact ISMP for pricing

Chain Pharmacies & Multi Site organizations: contact ISMP for pricing


 

Personal Subscription

Subscription Information

  • $70.00 per year

  • Online access for one (1) user

  • No redistribution is permitted

Single Site Subscription

Subscription Information for healthcare organizations (e.g. hospitals, clinics, pharmacies)

  • $100.00 per year

  • Online access for up to 50 users within a single site organization

  • Permission to redistribute within single-site location 

  • Instructions to add users to a subscription will be emailed to the user purchasing the subscription

  • Please use your organization email address when subscribing

  • Chain pharmacies/Multi-site organizations: Contact ISMP for pricing

Browse Issues

This month's main topic: QuarterWatch™ (2016 Quarter 1 Data): Lessons Learned from Withdrawal of Zecuity Ppatch and Patient Difficulties Using Tanzeum pen
This month's main topic: QuarterWatch™ Latest Edition: Cancer Risks with Biological Products for Psoriasis and Sudden Hearing Loss with Tadalafil and Sildenafil
In this month's issue: Government and Industry Fail to Protect the Public when They Suggest “Carefully Following Instructions” is Enough to Prevent Vaccine Errors
This month's main topic: QuarterWatch™ 2015 Quarter 1 and 2 Report: Focus on a New Sleep Medication, Changing Opioid Use, and New Diabetes Medications

Problem: Pharmacists and veterinarians should be aware of the potential for animal injury due to confusion between human drugs and animal drugs that have lookalike or sound-alike names. The US Food and Drug Administration (FDA) Center for Veterinary Medicine (CVM) has recently received a report of a dog mistakenly receiving the human drug SINEQUAN (doxepin) instead of the prescribed animal drug ZENIQUIN (marbofloxacin). The dog became ill (lethargy, anorexia, and oliguria) 24 hours after being administered the SINEquan. Fortunately, the dog was treated and recovered.

Drug name confusions...